Next Article in Journal
Hydrogen Desorption Properties of LiBH4/xLiAlH4 (x = 0.5, 1, 2) Composites
Previous Article in Journal
Ultrasonic Degradation of Konjac Glucomannan and the Effect of Freezing Combined with Alkali Treatment on Their Rheological Profiles
Previous Article in Special Issue
A Review on Daphnane-Type Diterpenoids and Their Bioactive Studies
Article Menu
Issue 10 (May-2) cover image

Export Article

Open AccessCommunication

Anti-Inflammatory Compounds from Atractylodes macrocephala

College of Pharmacy, Sookmyung Women’s University, Seoul 04310, Korea
School of Industrial Bio-Pharmaceutical Science, Semyung University, Jecheon, Chungbuk 27136, Korea
Author to whom correspondence should be addressed.
Academic Editors: Isabel Ferreira and Nancy D. Turner
Molecules 2019, 24(10), 1859;
Received: 22 April 2019 / Revised: 10 May 2019 / Accepted: 13 May 2019 / Published: 14 May 2019
(This article belongs to the Collection Bioactive Compounds)
PDF [780 KB, uploaded 15 May 2019]
  |     |  


In relation to anti-inflammatory agents from medicinal plants, we have isolated three compounds from Atractylodes macrocephala; 1, 2-[(2E)-3,7-dimethyl-2,6-octadienyl]-6-methyl-2, 5-cyclohexadiene-1, 4-dione; 2, 1-acetoxy-tetradeca-6E,12E-diene-8, 10-diyne-3-ol; 3, 1,3-diacetoxy-tetradeca-6E, 12E-diene-8, 10-diyne. Compounds 13 showed concentration-dependent inhibitory effects on production of nitric oxide (NO) and prostaglandin E2 (PGE2) in lipopolysaccharide (LPS)-activated RAW 264.7 macrophages. Western blotting and RT-PCR analyses demonstrated that compounds 13 suppressed the protein and mRNA levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Furthermore, compounds 13 inhibited transcriptional activity of nuclear factor-κB (NF-κB) and nuclear translocation of NF-κB in LPS-activated RAW 264.7 cells. The most active compound among them, compound 1, could reduce the mRNA levels of pro-inflammatory cytokines (IL-1β, IL-6 and TNF-α) and suppress the phosphorylation of MAPK including p38, JNK, and ERK1/2. Taken together, these results suggest that compounds 13 from A. macrocephala can be therapeutic candidates to treat inflammatory diseases. View Full-Text
Keywords: nitric oxide; prostaglandin E2; inducible nitric oxide synthase; cyclooxygenase-2; nuclear factor-κB; Atractylodes macrocephala nitric oxide; prostaglandin E2; inducible nitric oxide synthase; cyclooxygenase-2; nuclear factor-κB; Atractylodes macrocephala

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Jeong, D.; Dong, G.-Z.; Lee, H.J.; Ryu, J.-H. Anti-Inflammatory Compounds from Atractylodes macrocephala. Molecules 2019, 24, 1859.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top